Pediatrix Medical (MD) Equity Average (2010 - 2026)

Pediatrix Medical has disclosed Equity Average across 17 years of filings, most recently posting $872.2 million for Q1 2026.

• In Q1 2026, Equity Average rose 12.25% year-over-year to $872.2 million; the TTM figure through Mar 2026 stood at $872.2 million (up 12.25% YoY), while the FY2025 annual figure was $815.4 million, up 1.04% from the prior year.
• Equity Average fell to $872.2 million in Q1 2026, from $878.3 million in the prior quarter.
• Over the last five years, Equity Average for MD reached as high as $955.2 million in Q3 2023 and fell as low as $719.5 million in Q3 2024.
• The 5-year median for Equity Average is $862.2 million (2025), against an average of $851.1 million.
• Annual changes were most pronounced in 2024 — Equity Average slipped 24.68% — and 2025, when it rose 19.84%.
• A 5-year view of Equity Average shows it stood at $875.1 million in 2022, then increased by 3.81% to $908.5 million in 2023, then declined by 17.59% to $748.7 million in 2024, then advanced by 17.3% to $878.3 million in 2025, then fell by 0.69% to $872.2 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $872.2 million, $878.3 million, and $862.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.